Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - Djomkam, Alexandra Lindsey Zune; Olwal, Charles Ochieng'; Sala, Theodore Beyeme; Paemka, Lily (Frontiers in Oncology, 2020)